Back to Search
ANDREW SZALAY, MD
MD
Family Medicine Physician
NPI: 1679657381IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1998
Research & Publications (20)
Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy.
PMID 19617539·Proc Natl Acad Sci U S A·2009
7-preclinical
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.
PMID 19583830·BMC Genomics·2009
7-preclinical
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.
PMID 19470726·Clin Cancer Res·2009
7-preclinical
The immunologic aspects of poxvirus oncolytic therapy.
PMID 19266198·Cancer Immunol Immunother·2009
6-review
Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
PMID 19139123·Mol Cancer Ther·2009
7-preclinical
Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model.
PMID 19035444·Int J Cancer·2009
7-preclinical
Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
PMID 18949014·Cancer Gene Ther·2009
7-preclinical
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
PMID 18754710·Hum Gene Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7210 ROOSEVELT WAY NE
SEATTLE, WA 98115 - Phone
- (206) 320-3400
Quick Facts
- NPI
- 1679657381
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile